Ligand Pharmaceuticals
LGND
#3644
Rank
S$4.88 B
Marketcap
S$248.32
Share price
2.50%
Change (1 day)
61.42%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2025 (TTM): S$80.67 Million

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are S$0.25 Billion. In 2024 the company made an earning of S$7.02 Million a decrease over its 2023 earnings that were of S$81.41 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$80.67 M1048.11%
2024 S$7.02 M-91.37%
2023 S$81.41 M-7.59%
2022 S$88.1 M4%
2021 S$84.71 M296.42%
2020 S$21.37 M-97.97%
2019 S$1.05 B275.62%
2018 S$0.28 B237.48%
2017 S$83.12 M49.05%
2016 S$55.76 M55.41%
2015 S$35.88 M36.87%
2014 S$26.21 M29.59%
2013 S$20.23 M1309.35%
2012 S$1.43 M-43.97%
2011 S$2.56 M-113.19%
2010 -S$19.43 Million59.86%
2009 -S$12.16 Million-61.33%
2008 -S$31.43 Million-58.75%
2007 -S$76.18 Million20.52%
2006 -S$63.21 Million81.27%
2005 -S$34.87 Million
2003 -S$24.28 Million-20.6%
2002 -S$30.58 Million4.38%
2001 -S$29.29 Million-48.83%
2000 -S$57.24 Million-19.74%
1999 -S$71.32 Million-19.06%
1998 -S$88.11 Million126.71%
1997 -S$38.87 Million-5.83%
1996 -S$41.27 Million136.23%
1995 -S$17.47 Million-33.97%
1994 -S$26.46 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$41.00 B 48,402.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$15.00 B 17,644.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$28.48 B 33,591.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$10.43 B 12,242.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-S$0.35 Billion-504.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$29.22 B 34,469.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$10.16 B 11,926.71%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$11.80 B 13,857.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-S$78.34 Million-192.65%๐Ÿ‡บ๐Ÿ‡ธ USA